Literature DB >> 9950275

Submicron cationic emulsions as a new delivery system for oligonucleotides.

H Teixeira1, C Dubernet, F Puisieux, S Benita, P Couvreur.   

Abstract

PURPOSE: The main purpose of the present study was to investigate submicron emulsions as potential oligonucleotide (ON) delivery system.
METHODS: Submicron emulsions containing various concentrations of stearylamine (SA) were prepared by microfluidization. After association with model oligothymidylates, these emulsions were characterized in terms of particle size, zeta-potential, association efficiency and release upon dilution. The interactions between ON and SA were investigated by partitioning studies between water and oily phases, with ON of three different lengths (pdT16, pdT30, pdT50). The stability of pdT16 in the presence of nucleases was evaluated by incubation in cell culture medium supplemented with 10% of foetal calf serum.
RESULTS: The ON association efficiency was much higher with emulsions containing SA (E(SA)) than with control emulsions (E0), whatever the ON length. In addition, E(SA) was shown to protect ON against degradation for up to 3 hours in culture medium. ON and SA were able to form ion-pairs and the resulting complex was found to be insoluble both in water and in oil. Zeta potential was maintained constant when increasing the ON concentration, until flocculation occurred (up to 250 microM in the case of pdT16 for example). This has been explained by the presence of SA in excess, soluble in the oily core of droplets, able to migrate towards the interface and replacing SA neutralized in ion-pairs.
CONCLUSIONS: ESA appears to be a valuable system for delivery of ON and might even be improved by selecting an oily phase in which the SA/ON complex would be soluble.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950275     DOI: 10.1023/a:1018806425667

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV).

Authors:  M Berton; S Sixou; R Kravtzoff; C Dartigues; L Imbertie; C Allal; G Favre
Journal:  Biochim Biophys Acta       Date:  1997-01-10

2.  Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.

Authors:  O Zelphati; F C Szoka
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

3.  Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle.

Authors:  S H Klang; J Frucht-Pery; A Hoffman; S Benita
Journal:  J Pharm Pharmacol       Date:  1994-12       Impact factor: 3.765

4.  Fate of cationic liposomes and their complex with oligonucleotide in vivo.

Authors:  D C Litzinger; J M Brown; I Wala; S A Kaufman; G Y Van; C L Farrell; D Collins
Journal:  Biochim Biophys Acta       Date:  1996-06-11

5.  Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier.

Authors:  I Aynié; C Vauthier; M Foulquier; C Malvy; E Fattal; P Couvreur
Journal:  Anal Biochem       Date:  1996-09-05       Impact factor: 3.365

6.  Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.

Authors:  A R Thierry; A Rahman; A Dritschilo
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

7.  Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides.

Authors:  C Emile; D Bazile; F Herman; C Helene; M Veillard
Journal:  Drug Deliv       Date:  1996       Impact factor: 6.419

8.  Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.

Authors:  K Lappalainen; A Urtti; E Söderling; I Jääskeläinen; K Syrjänen; S Syrjänen
Journal:  Biochim Biophys Acta       Date:  1994-12-30

9.  Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake.

Authors:  C Chavany; T Saison-Behmoaras; T Le Doan; F Puisieux; P Couvreur; C Hélène
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

10.  Cationic lipid binding to DNA: characterization of complex formation.

Authors:  F M Wong; D L Reimer; M B Bally
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

View more
  3 in total

1.  New bicompartmental structures are observed when stearylamine is mixed with triglyceride emulsions.

Authors:  H Teixeira; C Dubernet; V Rosilio; S Benita; J Lepault; I Erk; P Couvreur
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

Review 2.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

3.  A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod.

Authors:  Zhongkun Zhang; Jimmy Chun-Tien Kuo; Chi Zhang; Yirui Huang; Zerui Zhou; Robert J Lee
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.